Covaxin phase 2 trial results show better reactogenicity, safety: Lancet studysource https://www.indiatoday.in/coronavirus-outbreak/story/covaxin-bharat-biotech-covid-vaccine-phase-2-results-efficacy-lancet-1777159-2021-03-09?utm_source=rss
Covaxin phase 2 trial results show better reactogenicity, safety: Lancet study
Covaxin phase 2 trial results show better reactogenicity, safety: Lancet studysource https://www.indiatoday.in/coronavirus-outbreak/story/covaxin-bharat-biotech-covid-vaccine-phase-2-results-efficacy-lancet-1777159-2021-03-09?utm_source=rss
Post a Comment